Skip Navigation


Journal of the National Cancer Institute Advance Access originally published online on November 27, 2007
JNCI Journal of the National Cancer Institute 2007 99(23):1748-1749; doi:10.1093/jnci/djm259
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
99/23/1748    most recent
djm259v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by McNeil, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McNeil, C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© Oxford University Press 2007.

NEWS

New NSCLC Staging Raises Treatment Issues

Caroline McNeil

The first 10% of the full text of this article appears below.

Oncologists may consider more patients for surgery and adjuvant therapy under a revised staging system for non–small-cell lung cancer (NSCLC) recommended by the International Association for the Study of Lung Cancer.

Because staging groups patients according to their prognosis, which helps determine therapy, the new system raises important questions about treatment. Some will ultimately have to be answered through additional clinical trials, said Peter Goldstraw, F.R.C.S., of Royal Brompton Hospital and Imperial College in London, who presented the proposed revisions in September at the 12th World Conference on Lung Cancer in Seoul, Korea. In the meantime, he said, "it will have an impact on the discussions in every multidisciplinary meeting about treating patients with lung cancer around the world."


Figure Removed (Available Only in the Full Text)
View larger version (112K):



  		Peter Goldstraw, F.R.C.S.

 
The proposed system is now under consideration by the International Union Against Cancer in Geneva and the American . . . [Full Text of this Article]

Important Stage Shifts

Coming Soon to Staging


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?